vs
Axogen, Inc.（AXGN）与electroCore, Inc.（ECOR）财务数据对比。点击上方公司名可切换其他公司
Axogen, Inc.的季度营收约是electroCore, Inc.的6.5倍（$59.9M vs $9.2M）。Axogen, Inc.净利率更高（-22.0% vs -32.8%，领先10.9%）。electroCore, Inc.同比增速更快（31.2% vs 21.3%）。过去两年electroCore, Inc.的营收复合增速更高（30.3% vs 20.3%）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
electroCore是一家总部位于美国新泽西州巴斯金里奇的医疗科技公司，于2005年由四位联合创始人创立，现任首席执行官为Daniel S. Goldberger。公司主打产品为gammaCore，是一款已实现商业化的非侵入式设备，通过迷走神经刺激发挥作用。
AXGN vs ECOR — 直观对比
营收规模更大
AXGN
是对方的6.5倍
$9.2M
营收增速更快
ECOR
高出9.9%
21.3%
净利率更高
AXGN
高出10.9%
-32.8%
两年增速更快
ECOR
近两年复合增速
20.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $59.9M | $9.2M |
| 净利润 | $-13.2M | $-3.0M |
| 毛利率 | 74.1% | 88.4% |
| 营业利润率 | -16.3% | -31.8% |
| 净利率 | -22.0% | -32.8% |
| 营收同比 | 21.3% | 31.2% |
| 净利润同比 | -3023.6% | 6.0% |
| 每股收益（稀释后） | $-0.28 | $-0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNECOR
| Q4 25 | $59.9M | $9.2M | ||
| Q3 25 | $60.1M | $8.7M | ||
| Q2 25 | $56.7M | $7.4M | ||
| Q1 25 | $48.6M | $6.7M | ||
| Q4 24 | $49.4M | $7.0M | ||
| Q3 24 | $48.6M | $6.6M | ||
| Q2 24 | $47.9M | $6.1M | ||
| Q1 24 | $41.4M | $5.4M |
净利润AXGNECOR
| Q4 25 | $-13.2M | $-3.0M | ||
| Q3 25 | $708.0K | $-3.4M | ||
| Q2 25 | $579.0K | $-3.7M | ||
| Q1 25 | $-3.8M | $-3.9M | ||
| Q4 24 | $450.0K | $-3.2M | ||
| Q3 24 | $-1.9M | $-2.5M | ||
| Q2 24 | $-1.9M | $-2.7M | ||
| Q1 24 | $-6.6M | $-3.5M |
毛利率AXGNECOR
| Q4 25 | 74.1% | 88.4% | ||
| Q3 25 | 76.6% | 86.0% | ||
| Q2 25 | 74.2% | 87.3% | ||
| Q1 25 | 71.9% | 84.9% | ||
| Q4 24 | 76.1% | 85.9% | ||
| Q3 24 | 74.9% | 83.8% | ||
| Q2 24 | 73.8% | 86.3% | ||
| Q1 24 | 78.8% | 83.7% |
营业利润率AXGNECOR
| Q4 25 | -16.3% | -31.8% | ||
| Q3 25 | 3.2% | -33.2% | ||
| Q2 25 | 3.0% | -47.5% | ||
| Q1 25 | -3.4% | -56.9% | ||
| Q4 24 | 4.1% | -43.6% | ||
| Q3 24 | -0.6% | -40.4% | ||
| Q2 24 | -0.9% | -42.2% | ||
| Q1 24 | -11.0% | -70.7% |
净利率AXGNECOR
| Q4 25 | -22.0% | -32.8% | ||
| Q3 25 | 1.2% | -39.2% | ||
| Q2 25 | 1.0% | -49.7% | ||
| Q1 25 | -7.9% | -57.4% | ||
| Q4 24 | 0.9% | -45.8% | ||
| Q3 24 | -3.8% | -38.1% | ||
| Q2 24 | -4.0% | -43.2% | ||
| Q1 24 | -16.0% | -64.4% |
每股收益（稀释后）AXGNECOR
| Q4 25 | $-0.28 | $-0.34 | ||
| Q3 25 | $0.01 | $-0.40 | ||
| Q2 25 | $0.01 | $-0.44 | ||
| Q1 25 | $-0.08 | $-0.47 | ||
| Q4 24 | $-0.00 | $-0.37 | ||
| Q3 24 | $-0.04 | $-0.31 | ||
| Q2 24 | $-0.04 | $-0.38 | ||
| Q1 24 | $-0.15 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.5M | $11.6M |
| 总债务越低越好 | $48.4M | $7.8M |
| 股东权益账面价值 | $128.8M | $-1.7M |
| 总资产 | $221.7M | $18.7M |
| 负债/权益比越低杠杆越低 | 0.38× | — |
8季度趋势，按日历期对齐
现金及短期投资AXGNECOR
| Q4 25 | $41.5M | $11.6M | ||
| Q3 25 | $35.8M | $13.0M | ||
| Q2 25 | $29.9M | $7.1M | ||
| Q1 25 | $22.1M | $7.8M | ||
| Q4 24 | $33.5M | $12.2M | ||
| Q3 24 | $24.5M | $12.9M | ||
| Q2 24 | $21.1M | $14.2M | ||
| Q1 24 | $17.6M | $7.8M |
总债务AXGNECOR
| Q4 25 | $48.4M | $7.8M | ||
| Q3 25 | $48.2M | $7.8M | ||
| Q2 25 | $47.9M | — | ||
| Q1 25 | $47.7M | — | ||
| Q4 24 | $47.5M | — | ||
| Q3 24 | $47.3M | — | ||
| Q2 24 | $47.0M | — | ||
| Q1 24 | $46.8M | — |
股东权益AXGNECOR
| Q4 25 | $128.8M | $-1.7M | ||
| Q3 25 | $120.8M | $-1.1M | ||
| Q2 25 | $112.3M | $1.1M | ||
| Q1 25 | $105.4M | $4.4M | ||
| Q4 24 | $103.9M | $7.5M | ||
| Q3 24 | $99.4M | $9.5M | ||
| Q2 24 | $95.7M | $11.5M | ||
| Q1 24 | $93.2M | $4.5M |
总资产AXGNECOR
| Q4 25 | $221.7M | $18.7M | ||
| Q3 25 | $216.4M | $21.4M | ||
| Q2 25 | $205.5M | $14.6M | ||
| Q1 25 | $196.2M | $16.0M | ||
| Q4 24 | $203.7M | $20.5M | ||
| Q3 24 | $192.0M | $21.0M | ||
| Q2 24 | $188.9M | $22.4M | ||
| Q1 24 | $186.5M | $13.9M |
负债/权益比AXGNECOR
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $1.8M | — |
| 自由现金流率自由现金流/营收 | 3.0% | — |
| 资本支出强度资本支出/营收 | 2.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-2.9M | — |
8季度趋势，按日历期对齐
经营现金流AXGNECOR
| Q4 25 | $3.0M | $-1.5M | ||
| Q3 25 | $3.2M | $-1.7M | ||
| Q2 25 | $7.7M | $-623.0K | ||
| Q1 25 | $-13.2M | $-4.4M | ||
| Q4 24 | $8.7M | $-1.3M | ||
| Q3 24 | $3.9M | $-1.4M | ||
| Q2 24 | $4.2M | $-1.8M | ||
| Q1 24 | $-12.3M | $-2.6M |
自由现金流AXGNECOR
| Q4 25 | $1.8M | — | ||
| Q3 25 | $1.7M | $-1.7M | ||
| Q2 25 | $7.0M | $-648.0K | ||
| Q1 25 | $-13.4M | $-4.4M | ||
| Q4 24 | $8.1M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $-13.2M | — |
自由现金流率AXGNECOR
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.8% | -19.3% | ||
| Q2 25 | 12.4% | -8.8% | ||
| Q1 25 | -27.7% | -65.4% | ||
| Q4 24 | 16.3% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | -31.9% | — |
资本支出强度AXGNECOR
| Q4 25 | 2.1% | 0.0% | ||
| Q3 25 | 2.5% | 0.0% | ||
| Q2 25 | 1.3% | 0.3% | ||
| Q1 25 | 0.5% | 0.6% | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.2% | — |
现金转化率AXGNECOR
| Q4 25 | — | — | ||
| Q3 25 | 4.55× | — | ||
| Q2 25 | 13.35× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 19.41× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
